chemours co slashed its fullyear guidance for adjusted earnings before interest taxes depreciation and amortization due to falling demand in europe and asia affecting the chemicals companys titanium technologies segment the company said it now expects adjusted ebitda for 2022 of 14 billion to 145 billion the midpoint of the new range is about 7 lower than the midpoint of the companys prior range but it still reflects growth of about 9 over 2021 chemours said the company said it expects free cash flow for the year of more than 575 million including actions to cut fullyear expenses from 400 million to about 350 million in our tt segment we have experienced a continued decline in our demand outlook throughout the third quarter most notably in europe and asia chief executive mark newman said lower demand coupled with continued high input costs have impacted our projected results for the full year in response we will be extending a scheduled outage on one of our tt production lines in addition to other cost actions mr newman said the company still expects to drive earnings growth in its thermal  specialized solutions and advanced performance segments as recently as july chemours said it was targeting the high end of its adjusted ebitda guidance range which was 1475 billion to 1575 billion at the time the company also said it was increasing its free cash flow outlook to greater than 600 million shares of chemours fell almost 5 to 2924 in premarket trading write to will feuer at willfeuerwsjcom